239 related articles for article (PubMed ID: 19767736)
1. Conformational inhibition of the hepatitis C virus internal ribosome entry site RNA.
Parsons J; Castaldi MP; Dutta S; Dibrov SM; Wyles DL; Hermann T
Nat Chem Biol; 2009 Nov; 5(11):823-5. PubMed ID: 19767736
[TBL] [Abstract][Full Text] [Related]
2. Screening for inhibitors of the hepatitis C virus internal ribosome entry site RNA.
Zhou S; Rynearson KD; Ding K; Brunn ND; Hermann T
Bioorg Med Chem; 2013 Oct; 21(20):6139-44. PubMed ID: 23602522
[TBL] [Abstract][Full Text] [Related]
3. Structure of the HCV Internal Ribosome Entry Site Subdomain IIa RNA in Complex with a Viral Translation Inhibitor.
Dibrov SM; Hermann T
Methods Mol Biol; 2016; 1320():329-35. PubMed ID: 26227053
[TBL] [Abstract][Full Text] [Related]
4. Tricistronic hepatitis C virus subgenomic replicon expressing double transgenes.
Cheng X; Gao XC; Wang JP; Yang XY; Wang Y; Li BS; Kang FB; Li HJ; Nan YM; Sun DX
World J Gastroenterol; 2014 Dec; 20(48):18284-95. PubMed ID: 25561795
[TBL] [Abstract][Full Text] [Related]
5. Aryl-substituted aminobenzimidazoles targeting the hepatitis C virus internal ribosome entry site.
Ding K; Wang A; Boerneke MA; Dibrov SM; Hermann T
Bioorg Med Chem Lett; 2014 Jul; 24(14):3113-7. PubMed ID: 24856063
[TBL] [Abstract][Full Text] [Related]
6. SAR by MS: discovery of a new class of RNA-binding small molecules for the hepatitis C virus: internal ribosome entry site IIA subdomain.
Seth PP; Miyaji A; Jefferson EA; Sannes-Lowery KA; Osgood SA; Propp SS; Ranken R; Massire C; Sampath R; Ecker DJ; Swayze EE; Griffey RH
J Med Chem; 2005 Nov; 48(23):7099-102. PubMed ID: 16279767
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis C virus RNA translation.
Niepmann M
Curr Top Microbiol Immunol; 2013; 369():143-66. PubMed ID: 23463200
[TBL] [Abstract][Full Text] [Related]
8. Ligand Optimization by Improving Shape Complementarity at a Hepatitis C Virus RNA Target.
Charrette BP; Boerneke MA; Hermann T
ACS Chem Biol; 2016 Dec; 11(12):3263-3267. PubMed ID: 27775338
[TBL] [Abstract][Full Text] [Related]
9. The hepatitis C virus internal ribosome-entry site: a new target for antiviral research.
Gallego J; Varani G
Biochem Soc Trans; 2002 Apr; 30(2):140-5. PubMed ID: 12023841
[TBL] [Abstract][Full Text] [Related]
10. Sequence-specific cleavage of hepatitis C virus RNA by DNAzymes: inhibition of viral RNA translation and replication.
Roy S; Gupta N; Subramanian N; Mondal T; Banerjea AC; Das S
J Gen Virol; 2008 Jul; 89(Pt 7):1579-1586. PubMed ID: 18559927
[TBL] [Abstract][Full Text] [Related]
11. Human La antigen is required for the hepatitis C virus internal ribosome entry site-mediated translation.
Ali N; Pruijn GJ; Kenan DJ; Keene JD; Siddiqui A
J Biol Chem; 2000 Sep; 275(36):27531-40. PubMed ID: 10856291
[TBL] [Abstract][Full Text] [Related]
12. The functional RNA domain 5BSL3.2 within the NS5B coding sequence influences hepatitis C virus IRES-mediated translation.
Romero-López C; Berzal-Herranz A
Cell Mol Life Sci; 2012 Jan; 69(1):103-13. PubMed ID: 21598019
[TBL] [Abstract][Full Text] [Related]
13. Increased inhibitory ability of conjugated RNA aptamers against the HCV IRES.
Kikuchi K; Umehara T; Nishikawa F; Fukuda K; Hasegawa T; Nishikawa S
Biochem Biophys Res Commun; 2009 Aug; 386(1):118-23. PubMed ID: 19501043
[TBL] [Abstract][Full Text] [Related]
14. Interferons specifically suppress the translation from the internal ribosome entry site of hepatitis C virus through a double-stranded RNA-activated protein kinase-independent pathway.
Kato J; Kato N; Moriyama M; Goto T; Taniguchi H; Shiratori Y; Omata M
J Infect Dis; 2002 Jul; 186(2):155-63. PubMed ID: 12134250
[TBL] [Abstract][Full Text] [Related]
15. Genetic analysis of a poliovirus/hepatitis C virus chimera: new structure for domain II of the internal ribosomal entry site of hepatitis C virus.
Zhao WD; Wimmer E
J Virol; 2001 Apr; 75(8):3719-30. PubMed ID: 11264361
[TBL] [Abstract][Full Text] [Related]
16. Structure of a hepatitis C virus RNA domain in complex with a translation inhibitor reveals a binding mode reminiscent of riboswitches.
Dibrov SM; Ding K; Brunn ND; Parker MA; Bergdahl BM; Wyles DL; Hermann T
Proc Natl Acad Sci U S A; 2012 Apr; 109(14):5223-8. PubMed ID: 22431596
[TBL] [Abstract][Full Text] [Related]
17. Short peptide nucleic acids (PNA) inhibit hepatitis C virus internal ribosome entry site (IRES) dependent translation in vitro.
Alotte C; Martin A; Caldarelli SA; Di Giorgio A; Condom R; Zoulim F; Durantel D; Hantz O
Antiviral Res; 2008 Dec; 80(3):280-7. PubMed ID: 18625270
[TBL] [Abstract][Full Text] [Related]
18. 2-Aminobenzoxazole ligands of the hepatitis C virus internal ribosome entry site.
Rynearson KD; Charrette B; Gabriel C; Moreno J; Boerneke MA; Dibrov SM; Hermann T
Bioorg Med Chem Lett; 2014 Aug; 24(15):3521-5. PubMed ID: 24930829
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C virus internal ribosome entry site (IRES) stem loop IIId contains a phylogenetically conserved GGG triplet essential for translation and IRES folding.
Jubin R; Vantuno NE; Kieft JS; Murray MG; Doudna JA; Lau JY; Baroudy BM
J Virol; 2000 Nov; 74(22):10430-7. PubMed ID: 11044087
[TBL] [Abstract][Full Text] [Related]
20. A peptide derived from RNA recognition motif 2 of human la protein binds to hepatitis C virus internal ribosome entry site, prevents ribosomal assembly, and inhibits internal initiation of translation.
Pudi R; Ramamurthy SS; Das S
J Virol; 2005 Aug; 79(15):9842-53. PubMed ID: 16014945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
